Our Courses
Explore our selection of cutting-edge courses accredited for CME.
All our educational activities are free of charge.
Epilepsy As A Shared Journey: From Patient Needs To Expert Support
Engage with this interactive e-medi case study designed to enhance your understanding of the burden and challenges associated with epilepsy care, improving your knowledge and skills.
The Identification and Diagnosis of Lennox-Gastaut Syndrome (LGS)
Join our expert panel in a course accredited for CME featuring a webinar and interactive case study that focuses on the identification and diagnosis of developmental and epileptic encephalopathies (DEE), with a specific focus on Lennox-Gastaut Syndrome (LGS).
The Use of Angiotensin II in Vasodilatory Shock
Join our panel of experts in the field of intensive care for this webinar accredited for CME covering vasodilatory shock, the current vasoactive agents, and a critical evaluation of emerging therapies including angiotensin II.
Clarity on JAK inhibitors in the treatment of IBD
Join our panel of experts in gastroenterology and inflammatory bowel disease (IBD) for this two-part webinar series accredited for CME on Janus kinase (JAK) inhibitors and their application in clinical practice for IBD considering the recent European Medical Agency (EMA) and U.S. Food and Drug Administration (FDA) recommendations.
Webinar 1 provides an overview of JAK inhibitors, mechanisms of action, clinical data, and a discussion around current clinical practices.
Webinar 2 provides a roundtable discussion around JAK inhibitor safety data, recommendations, and implications for
clinical practice.
Interchangeable Biosimilars
Join our panel of experts in the field of biologics for this webinar accredited for CME where they provide up-to-date knowledge of the current regulatory environment on the interchangeability of biosimilars, with reflections on the clinical attributes, and a critical evaluation of the current use of biosimilars.
Biosimilars within Haematology & Oncology
This presidential debate-style discussion explores the topic of biosimilars within haematology and oncology.
Jonathan Sackier moderates the session alongside an expert panel sharing viewpoints from their backgrounds in pharmacology, industry and clinical medicine.